<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01658592</url>
  </required_header>
  <id_info>
    <org_study_id>NAc-VC DBS for alcohol addict</org_study_id>
    <nct_id>NCT01658592</nct_id>
  </id_info>
  <brief_title>Deep Brain Stimulation of the Nucleus Accumbens and the Ventral Anterior Internal Capsule for Severe Alcohol Addiction</brief_title>
  <official_title>Deep Brain Stimulation of the Nucleus Accumbens and the Ventral Anterior Internal Capsule as a Novel Treatment in Severe Alcohol Addiction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guodong Gao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to assess the efficacy of bilateral deep brain
      stimulation (DBS) of the nucleus accumbens (NAc) and the ventral anterior internal capsule
      (VC) as a novel treatment in severe alcohol addiction. The included patients have been
      treated so far with drugs that inhibits alcohol, or psychological behavior training.

      Our hypothesis is that bilateral NAc-VC DBS will significantly reduce the craving for alcohol
      and thus enable the patients to decrease their alcohol intake substantially.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The nucleus accumbens (NAc) is considered associating with addiction. The ventral anterior
      internal capsule(VC) is proved a effective target to obsessive compulsive disorder(OCD). Like
      other addiction behaviors most alcohol addicts contain obsessive compulsive symptom. We
      explored an operation method, that is, in the Leksell stereotactic positioning system take VC
      as the point of entry, take NAc as the point of target, then make sure that the distance
      between entry and target points are included in the four contacts of electrode of DBS. When
      stimulator is ON the investigators can adjust parameters so that the coverage of electrode
      contains both Vc and NAc. The investigators suppose that bilateral NAc-VC DBS will
      significantly reduce the craving for alcohol and thus enable the patients to decrease their
      alcohol intake substantially.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of Alcohol</measure>
    <time_frame>7 months</time_frame>
    <description>Reduction of the dosage of alcohol(all kinds of liquor were converted into pure alcohol) comparing baseline and the particular ward rounds during and at the end of the crossover-design.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Craving</measure>
    <time_frame>7 months</time_frame>
    <description>10-point visual analog scale (VAS) of craving</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Psychological components</measure>
    <time_frame>7 months</time_frame>
    <description>Addiction severity(ASI); Psychological components (Anxiety (BAI-21 item); Depression (BDI-21 item); Quality of life (WHOQL-Brief); Health condition(SF-36).</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Addiction</condition>
  <arm_group>
    <arm_group_label>NAC-VC Deep Brain Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The contractors located in NAc and VC are ON at the same time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo A</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Stimulator setting is OFF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The contractor located in NAc is on</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The contactor located in VC is on</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Deep brain stimulation</intervention_name>
    <description>Stimulator setting is ON</description>
    <arm_group_label>NAC-VC Deep Brain Stimulation</arm_group_label>
    <arm_group_label>Placebo A</arm_group_label>
    <arm_group_label>Placebo B</arm_group_label>
    <arm_group_label>Placebo C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Stimulator setting is OFF</description>
    <arm_group_label>NAC-VC Deep Brain Stimulation</arm_group_label>
    <arm_group_label>Placebo A</arm_group_label>
    <arm_group_label>Placebo B</arm_group_label>
    <arm_group_label>Placebo C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Long lasting alcohol addiction (fulfilled diagnostic-criteria according to
             DSM-IV,ICD-10)

          -  At least one detoxication-treatment without a long-term period of abstinence has
             already taken place

          -  Long-term inpatient treatment to support abstinence have occurred

          -  Free patient's decision / Informed Consent (existing comprehensive ability in meaning,
             methodology and execution of the study and ability of acceptance)

          -  If prior medication, stable dosage of psychopharmacological drugs over the last three
             months, which shall, after checking be retained during the study

        Exclusion Criteria:

          -  Hospitalization for psychotic symptoms

          -  Clinical relevant psychiatric comorbidity (such as schizophrenic psychoses, bipolar
             affective diseases, severe personality disorder, and so on. And diagnosed by criteria
             according to DSM-IV,ICD-10)

          -  Contraindications of a MRI-examination, e.g. implanted cardiac pacemaker/ heart
             defibrillator

          -  Current and in the last six months existent paranoid-hallucinated symptomatology

          -  Foreign aggressiveness in the last six months

          -  Verbal IQ &lt; 85 (evaluated with the Wechsler Adult Intelligence Scale- Chinese Revised
             (WAIS-CR)

          -  Stereotactic respectively neurosurgical intervention in the past

          -  Other neurological diseases

          -  Contraindications of a stereotactic operation, e.g. increased bleeding-disposition,
             cerebrovascular diseases (e.g. arteriovenous malfunction, aneurysms, systemic vascular
             diseases)

          -  Serious and instable organic diseases (e.g. instable coronal heart disease)

          -  tested positively for HIV

          -  pregnancy and/or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gao G Dong, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of neurosurgery, Tangdu Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gao G Dong, Doctor</last_name>
    <phone>+86 29-84777435</phone>
    <email>gguodong@fmmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wang X Lian, Doctor</last_name>
    <phone>+86 29-84777284</phone>
    <email>tdwxlian@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of neurosurgery, Tangdu Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gao G Dong, Doctor</last_name>
      <phone>+86 29-84777435</phone>
      <email>gguodong@fmmu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Wang X Lian, Doctor</last_name>
      <phone>+86 29-84777284</phone>
      <email>tdwxlian@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>Wang X Lian, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2012</study_first_submitted>
  <study_first_submitted_qc>August 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2012</study_first_posted>
  <last_update_submitted>August 2, 2012</last_update_submitted>
  <last_update_submitted_qc>August 2, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tang-Du Hospital</investigator_affiliation>
    <investigator_full_name>Guodong Gao</investigator_full_name>
    <investigator_title>Neurosurgery Department</investigator_title>
  </responsible_party>
  <keyword>Alcohol Addiction;</keyword>
  <keyword>Deep Brain Stimulation;</keyword>
  <keyword>Nucleus Accumbens;</keyword>
  <keyword>Ventral Anterior Internal capsule;</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Behavior, Addictive</mesh_term>
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

